Gland Pharma is coming out with an initial public offering (IPO) to raise around Rs 6,480 crore. The issue will open on November 9, 2020 and will close on November 11, 2020. It has fixed a price band of Rs 1,490- 1,500 per share. The shares of the company are proposed to be listed on both BSE and NSE.
The proceeds from the fresh issue of shares will be utilised for working capital, capital expenditure and general corporate purposes. The book running lead managers to the issue are Kotak Mahindra Capital Company, Citigroup Global Markets India, Haitong Securities India and Nomura Financial Advisory and Securities (India).
Gland Pharma develops, manufactures and markets complex injectables. The company sells its products primarily under a business-to-business model in over 60 countries, including the US, Canada, Australia and India.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1504.25 |
Dr. Reddys Lab | 6263.70 |
Cipla | 1406.25 |
Zydus Lifesciences | 948.20 |
Lupin | 1615.85 |
View more.. |